Sheetal Medicare Products IPO Details

SME NSE

Sheetal Medicare Products IPO Summary

Sheetal Medicare Products IPO DRHP (Draft Red Herring Prospectus) has been Filed with Exchange.

Sheetal Medicare Products IPO total issue size comprises 72,00,000 shares . This includes a fresh issue of 72,00,000 shares . Pre-issue shareholding stands at 1,71,69,600, which will increase to 2,43,69,600 post-issue.

Sheetal Medicare Products IPO carries a ₹0 (0%) GMP, reflecting investor sentiment.

The Lead Managers for Sheetal Medicare Products IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Mark Corporate Advisors Pvt Ltd . To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.

For detailed information, Refer to the Sheetal Medicare Products Limited DRHP.

Sheetal Medicare Products IPO Details

Open Date

Close Date

Listing Date

Issue Price

₹0 - ₹0

Face Value

₹10 per share

Lot Size

GMP

₹0

Issue Type

IPO

Listing On

NSE

Type

Fixed Price Issue

Pre-issue Shareholding

1,71,69,600 shares

Post-issue Shareholding

2,43,69,600 shares

Total Issue Size

72,00,000 shares

Fresh Issue

72,00,000 shares

Offer for Sale

DRHP Status

Filed with Exchange

Sheetal Medicare Products IPO Lot Size

Application	Lots	Shares	Amount
To be announced

Sheetal Medicare Products IPO Reservation

Promoter Holding

Pre Issue:

99.72%

Post Issue:

Promoter Names:

Mr. Sanjai Tiwari, Mr. Ajay Tewari, , Corporate Promoter M/s. Smartdata Enterprises Inc.

Documents

DRHP

Sheetal Medicare Products IPO DRHP

Sheetal Medicare Products IPO Valuations

ROE12.91%

ROCE13.58%

Debt/Equity0.18

RoNW11.64%

PAT Margin29.57%

EBITDA Margin40.56%

Sheetal Medicare Products Financial Information

Period Ended	30 Sep 2025	31 Mar 2025	31 Mar 2024
Assets	125.28	109.56	83.75
Total Income	38.52	78.69	71.42
Profit After Tax	10.56	19.01	5.83
EBITDA	14.47	22.04	9.10
NET Worth	90.76	80.20	61.19
Reserves and Surplus	89.69	79.13	60.12
Amount in ₹ Crore

About Sheetal Medicare Products IPO

Sheetal Medicare Products Limited, incorporated in 1997, is a healthcare and pharmaceutical manufacturing company engaged in the production of ayurvedic, herbal, and medicinal products. The company operates within the broader pharmaceuticals and botanical products segment, focusing on natural and traditional healthcare solutions.

The company’s product portfolio comprises a variety of herbal formulations, including oils, syrups, powders, tablets, and wellness products, catering to health and personal care requirements across the domestic market.

Sheetal Medicare Products Limited emphasizes the use of ayurvedic principles and natural ingredients, combining traditional knowledge with modern manufacturing processes to deliver quality healthcare products.

The company operates its manufacturing facility in Maharashtra, India, supporting its production and distribution activities.

As a small-to-mid scale herbal and pharmaceutical manufacturer, Sheetal Medicare Products Limited continues to focus on expanding its presence in the ayurvedic healthcare segment in India.

Strength Of Sheetal Medicare Products IPO

To be announced

Risk Of Sheetal Medicare Products IPO

To be announced

Objectives Sheetal Medicare Products IPO

1. Investment in designing and development of the products and platform

2. Funding Upgradation of the Company’s Digital Infrastructure (Software, Hardware and Communications & Network Services)

3. Funding capital expenditure for setting up development centres in Nagpur and Hyderabad

4. Repayment of certain outstanding borrowings availed by the Company

5. General Corporate Purposes

6. Total

Company Contact Details

P.No. I 23, Alpha IT City, Sector - 83, Mohali, Manauli, Rupnagar, S.A.S. Nagar
Mohali, Punjab , 140306
Phone: 91-0172-4346363
Email: investors.sdei@smartdatainc.net
Website: https://www.smartdatainc.com/

Registrar Contact Details

Name:

Skyline Financial Services Pvt Ltd

Phone:

+91-22-28511022

Email:

ipo@skylinerta.com

Website:

https://www.skylinerta.com/ipo.php

Lead Mangers

Market Maker

To be announced

Sheetal Medicare Products FAQs

The Sheetal Medicare Products IPO is a SME public issue comprising 7200000 equity shares with a face value of ₹10 each, aggregating to a total issue size of . The issue price has been fixed at ₹0 per equity share, and the minimum application size is shares.

The IPO opens for subscription on TBA, and closes on TBA.

Skyline Financial Services Pvt Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the NSE

The Sheetal Medicare Products IPO opens on TBA.

Sheetal Medicare Products IPO lot size is , and the minimum amount required for application is ₹.

You may apply for the Sheetal Medicare Products IPO online by using either the UPI or ASBA payment method. The ASBA facility is available through the net banking platform of your respective bank. The UPI-based IPO application option is typically provided by brokers that do not offer banking services. For detailed guidance on the online IPO application process, please refer to the procedures outlined by Zerodha, Groww, Upstox, 5Paisa, Paytm Money, Fyers, Alice Blue, Nuvama, HDFC Bank, ICICI Direct, Kotak Securities, Axis Direct, and SBI Bank.

The Basis of Allotment for the Sheetal Medicare Products IPO is scheduled to be finalized on TBA. Subsequently, the shares allotted will be credited to investors’ demat accounts by TBA. Investors are advised to regularly check the Sheetal Medicare Products IPO allotment status for updates.

The listing date for the Sheetal Medicare Products IPO has not yet been officially announced. However, the tentative listing date is scheduled for TBA.

Sheetal Medicare Products IPO Grey Market Premium (GMP) refers to the unofficial price at which the company’s IPO shares are traded in the grey market prior to their listing on the stock exchange. The GMP serves as an indicator of investor demand, expected listing gains, and the overall market sentiment toward the IPO.

As of now, the current GMP stands at TBA.